Be4ward

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    The DNA bottleneck: how synthetic manufacturing could unlock the next wave of gene editing therapies As gene-editing therapies evolve towards increasingly complex applications, 4basebio CEO Amy Walker (AW) tells Dr Kevin Robinson (KSR) how advances in scalable enzymatic DNA...
  2. Leading European CDMO Aenova expands automated semi-solids tube packaging capacity New state-of-the-art high-speed line boosts annual capacity to over 50 million tubes per year and enhances flexibility for pharmaceutical creams, gels and ointments
  3. Why integrated outsourcing wins in modern drug development Aligning drug substance and drug product development within a single outsourcing model accelerates timelines, sharpens CMC decisions and reduces risk by enabling parallel...
  4. AI-designed drug product enters clinical development Phase I study of an AI-designed oral formulation sets a new standard in drug development
  5. CelLBxHealth and AstraZeneca sign Master Services Agreement The new contract establishes CelLBxHealth as a qualified service provider to AstraZeneca, allowing it to support drug discovery and development through CTC-powered analytics of...

Upcoming event

BIO International Convention

22–25 June 2026 | Convention | Boston, US See all

Related Content

Regulatory

FMD Alerts in 2020: where we are a year into legislation

It’s been more than a year since EU FMD came into force in February 2019 and, after initial problems bedding in the new systems, false alerts remain a problem, preventing the realisation of the full benefits of the directive
Subscribe now